This week in IP licensing and business: Aug. 1-14

By Nick Robertson ( August 14, 2025, 17:48 GMT | Insight) -- Pharmaceutical deals led the way in patent business in the last two weeks. BioNTech and GSK grabbed headlines with a $500 million mRNA vaccine patent deal and settlement of infringement litigation, while AccessAdvance announced an expansion of its video codec patent licensing pool.In the past two weeks, major pharmaceutical and biotechnology companies agreed to licensing agreements which could be worth billions. Bayer made the largest deal, agreeing to pay up to $1.3 billion to Kumquat Biosciences for an exclusive license to a cancer treatment. In the video codec space, AccessAdvance announced changes to its Video Distribution Patent (VDP) Pool, while Advent Technologies announced an expanded agreement for advanced fuel cell technology with Los Alamos National Laboratory....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.

Know what others in the room don’t, with features including:

Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

This week in IP licensing and business: Aug. 1-14

Prepare for tomorrow’s regulatory change, today

Related Sections